Focus on Cdc42 in Breast Cancer: New Insights, Target Therapy Development and Non-Coding RNAs

Breast cancer is the most common malignant tumors in females. Although the conventional treatment has demonstrated a certain effect, some limitations still exist. The Rho guanosine triphosphatase (GTPase) Cdc42 (Cell division control protein 42 homolog) is often upregulated by some cell surface rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yu, Li, Jun, Lai, Xing-Ning, Jiao, Xue-Qiao, Xiong, Jun-Ping, Xiong, Li-Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406589/
https://www.ncbi.nlm.nih.gov/pubmed/30754684
http://dx.doi.org/10.3390/cells8020146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406589/
https://www.ncbi.nlm.nih.gov/pubmed/30754684
http://dx.doi.org/10.3390/cells8020146

Ejemplares similares